NDC 13537-053-01 - ESIKA Ultra Softening SPF 15
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13537-053
- Requested NDC
- 13537-053-01
- Package NDCs from labels
- 13537-053-01, 13537-053-02
- Manufacturer
- Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia)
- Effective date
- 2011-09-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Octinoxate - Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia) | Ventura Corporation (San Juan, P.R) | Bel Star S.A. (Colombia) | 2011-09-20 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 13537-053-02 | 2025-03-31 | C162847 | 48780-1 | 960f7f55-bf57-8e05-e053-dbdaa90a074a | Esika Ultra-Softening Lipstick FPS 15 |
| 13537-053-02 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-bf57-8e05-e053-dbdaa90a074a | Esika Ultra-Softening Lipstick FPS 15 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.